Journal article icon

Journal article

A vaccine against serogroup B Neisseria meningitidis: Dealing with uncertainty

Abstract:

Neisseria meningitidis is an important cause of invasive bacterial infection in children worldwide. Although serogroup C meningococcal disease has all but disappeared in the past decade as a direct result of immunisation programmes in Europe, Canada, and Australia, meningitis and septicaemia caused by serogroup B meningococci remain uncontrolled. A vaccine (4CMenB) has now been licensed for use in the European Union, comprising three immunogenic antigens (identified with use of reverse vaccin...

Expand abstract

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MPLS
Department:
Engineering Science
Sub department:
Institute of Biomedical Engineering
Role:
Author
Publisher:
Lancet
Journal:
Lancet Infectious Diseases
Volume:
14
Issue:
5
Pages:
426-434
Publication date:
2014-01-01
DOI:
EISSN:
1474-4457
ISSN:
1473-3099
Source identifiers:
464285
Language:
English
Pubs id:
pubs:464285
UUID:
uuid:36bcb8f9-3527-402e-918f-bd83af2b26af
Local pid:
pubs:464285
Deposit date:
2014-05-26

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP